This signature includes key genes for maintaining cellular cytotoxicity such as ZNF683,41PRF1, IL2RB, and IFNG and immune activation and exhaustion markers including LAG3, PDCD1, PRF1, and TBX21 that contribute to anti-tumor immunity. The gene discussed is IFNG; the disease is neoplasm.